Skip to content

The impact of long-acting local anesthetic for thoracic paravertebral nerve block on the quality of recovery after thoracoscopic surgery: A randomized controlled trial

The impact of long-acting local anesthetic for thoracic paravertebral nerve block on the quality of recovery after thoracoscopic surgery: A randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500101484
Enrollment
Unknown
Registered
2025-04-25
Start date
2025-04-30
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

Intervention group:Perform thoracic paravertebral nerve block using 10 ml of 0.5% bupivacaine and 10 ml of bupivacaine liposome.
Control group:Thoracic paravertebral nerve block was performed using 20ml of 0.5% ropivacaine

Sponsors

Beijing Chaoyang Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Adult patients aged 18-65 years who underwent thoracoscopic resection of lung cancer under general anesthesia

Exclusion criteria

Exclusion criteria: Preoperative ASA grade >=4; BMI>=35; Pregnancy and lactation; History of allergy to narcotic drugs; Preoperative use of opioid analgesics; Regional block anesthesia contraindicated; The expected duration of mechanical ventilation after operation is >6h; Refusing to sign a written informed consent

Design outcomes

Primary

MeasureTime frame
Postoperative recovery quality;Complication rate;

Secondary

MeasureTime frame
Postoperative pain VAS score;Postoperative sleep quality;The incidence of postoperative nausea and vomiting;Incidence of pain remediation;

Countries

China

Contacts

Public ContactYan Xiang

Beijing Chao-Yang Hospital

393870531@qq.com+86 185 1052 3195

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026